Veracyte, Inc. (VCYT)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreKey Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mr. Marc A. Stapley
|
CEO & Director | 1.53M | -- | 1970 |
|
Ms. Rebecca Chambers
|
Executive VP & CFO | 911.95k | -- | 1978 |
|
Dr. Phillip G. Febbo M.D.
|
Chief Scientific & Medical Officer | 930.09k | -- | 1966 |
|
Ms. Annie McGuire
|
Executive VP, General Counsel & Head of Market Access | 829.5k | -- | 1980 |
|
Dr. John Leite Ph.D.
|
Global Chief Commercial Officer | 846.49k | -- | 1972 |
|
Dr. Keith Gligorich Ph.D.
|
Senior Vice President of Global Operations | -- | -- | -- |
|
Mr. Jonathan Wygant
|
VP & Chief Accounting Officer | -- | -- | 1971 |
|
Dr. Kevin Richard Haas Ph.D.
|
Chief Development & Technology Officer | -- | -- | 1985 |
|
Mr. Steven French
|
Senior VP & Chief Information Officer | -- | -- | -- |
|
Ms. Kelly Gura
|
Director of Investor Relations | -- | -- | -- |
Veracyte, Inc.
- Sector:
- Healthcare
- Industry: Diagnostics & Research
- Full Time Employees:
- 755
Description
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Corporate Governance
Upcoming Events
November 4, 2026 at 8:00 PM UTC
Veracyte, Inc. Earnings Date
